Cargando…
Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer
Reliable factors predicting the disease course of non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) are unavailable. Molecular subtypes have potential for prognostic stratification of muscle-invasive bladder cancer, while their value for CIS patients is unknown. Here, the progn...
Autores principales: | Garczyk, Stefan, Bischoff, Felix, Schneider, Ursula, Golz, Reinhard, von Rundstedt, Friedrich-Carl, Knüchel, Ruth, Degener, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364543/ https://www.ncbi.nlm.nih.gov/pubmed/33650041 http://dx.doi.org/10.1007/s00428-021-03054-0 |
Ejemplares similares
-
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
por: Garczyk, Stefan, et al.
Publicado: (2022) -
Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications
por: Barth, Isabella, et al.
Publicado: (2018) -
ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
por: Garczyk, Stefan, et al.
Publicado: (2018) -
Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer
por: Lindskrog, Sia V., et al.
Publicado: (2023) -
Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy
por: Schnitzler, Tician, et al.
Publicado: (2020)